|
|
 |
ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALTABAX Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ETHYLCELLULOSE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DIETHYL PHTHALATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|